Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App.
Karen Lisa SmithHua-Ling TsaiDavid LimChenguang WangRaquel A NunesMary J WilkinsonJennifer Yeong-Shin ShengRima CouziJohn FettingCarol RileyAntonio C WolffCesar A Santa-MariaKatie PapathakisLauren Collins-ChaseChristie HiltonElissa ThornerAmanda MontanariDara IkejianiClaire F SnyderVered StearnsPublished in: JCO oncology practice (2023)
Symptom monitoring with ePROs during adjuvant ET is feasible. Despite infrequent documentation of pathway-concordant symptom management after symptom alerts, ePROs were associated with favorable short-term ET persistence.